Quantcast
Channel: ESG News and Media
Viewing all articles
Browse latest Browse all 17982

Sanofi – Cop 21 - First Step to Act on Infectious Diseases Evolution Due to Climate Change

$
0
0

SOURCE:Sanofi

DESCRIPTION:

Laurent Fraisse, head of research on infectious diseases at Sanofi, explains how research can help tackling infectious diseases evolution due to climate change.

Watch more Sanofi videos! Vist our YouTube page at SanofiTV!  

About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

 

Tweet me:Sanofi – Cop 21 - First Step to Act on Infectious Diseases Evolution Due to Climate Change. http://3bl.me/csyske

KEYWORDS: Environment and Climate Change, Sanofi, csr, Corporate Social Responsibility, COP21, climate change, Global Warming, Infectious Disease, co2 emission, environmental policy, dengue, Malaria, Dengue Fever


Viewing all articles
Browse latest Browse all 17982